Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedation July 2, 2020
French-American AI Startup Owkin Closes $18M Series A To Make Medical Research More Collaborative July 1, 2020
Blueprint Medicines Announces Submission of New Drug Application to FDA for Pralsetinib for the Treatment of Advanced RET Mutant and RET Fusion-Positive Thyroid Cancers July 1, 2020
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin July 1, 2020
Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders June 30, 2020
Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting June 27, 2020
PatientPing Launches Route Solution to Guarantee Hospital E-Notifications Condition of Participation Compliance Under CMS’s Interoperability and Patient Access Rule June 24, 2020